The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail

Gabapentin Auro 300 mg hard capsules

Aurobindo Pharma (Malta) LimitedPA1445/026/002

Main Information

Trade NameGabapentin Auro 300 mg hard capsules
Active SubstancesGabapentin
Dosage FormCapsule, hard
Licence HolderAurobindo Pharma (Malta) Limited
Licence NumberPA1445/026/002

Group Information

ATC CodeN03AX12 gabapentin


License statusAuthorised
Licence Issued21/10/2022
Legal statusProduct subject to prescription which may be renewed (B)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusUnknown


Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportPDF Version

Generics Information

Interchangeable ListGabapentin 300mg Capsules
Interchangeable List CodeIC0109-029-001
Interchangeable List DocumentPDF of Interchangeable List
« Back